-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
No data
undefined
Digestive Tract and Metabolism
Mecobalamin Injection
[Generic Name] Mecobalamin Injection
[Approval Number] National Drug Approval Number H20066715
[Specification] 1 ml: 0.5 mg
[Packaging Material] Glass Ampoule
【Dosage Form】Injection
Mecobalamin Injection
[Generic Name] Mecobalamin Injection
[Approval Number] National Drug Approval Number H20066715
[Specification] 1 ml: 0.5 mg
[Packaging Material] Glass Ampoule
【Dosage Form】Injection
Lipoic Acid Injection
[Generic Name] Lipoic Acid Injection
[Approval Number] National Drug Approval Number H20233115
【Specification】24 ml: 600 mg
[Packaging Material] Glass Ampoule
【Dosage Form】Injection
Lipoic Acid Injection
[Generic Name] Lipoic Acid Injection
[Approval Number] National Drug Approval Number H20233115
【Specification】24 ml: 600 mg
[Packaging Material] Glass Ampoule
【Dosage Form】Injection
Pralukasol Succinate Tablets
[Generic Name] Prucalopride Succinate Tablets
[Approval Number] National Drug Approval No. H20203309
【Specification】1 mg × 24 tablets
[Packaging] Double-aluminum packaging
[Medical Insurance] National Medical Insurance Category B
Pralukasol Succinate Tablets
[Generic Name] Prucalopride Succinate Tablets
[Approval Number] National Drug Approval No. H20203309
【Specification】1 mg × 24 tablets
[Packaging] Double-aluminum packaging
[Medical Insurance] National Medical Insurance Category B
Gliclazide II
[Generic Name] Gliclazide II
[Approval Number] National Drug Approval Number H20073781
【Specification】80mg × 20 tablets/blister × 3 blisters/box × 400 boxes/carton
[Packaging Material] Aluminum-plastic blister pack
[Medical Insurance] National Medical Insurance Category A
Gliclazide II
[Generic Name] Gliclazide II
[Approval Number] National Drug Approval Number H20073781
【Specification】80mg × 20 tablets/blister × 3 blisters/box × 400 boxes/carton
[Packaging Material] Aluminum-plastic blister pack
[Medical Insurance] National Medical Insurance Category A
Gliclazide I
[Generic Name] Gliclazide I
[Approval Number] National Drug Approval No. H13021831
【Specification】80mg × 60 tablets/box × 300 boxes/carton
[Packaging Material] Aluminum-plastic blister pack
【Medical Insurance】National Medical Insurance Category A
Gliclazide I
[Generic Name] Gliclazide I
[Approval Number] National Drug Approval No. H13021831
【Specification】80mg × 60 tablets/box × 300 boxes/carton
[Packaging Material] Aluminum-plastic blister pack
【Medical Insurance】National Medical Insurance Category A
Lisimin Granules
[Generic Name] Litemin Granules
[Approval Number] National Drug Approval No. Z20025976
[Specification] 5g × 6 sachets/box × 180 boxes/carton
[Packaging Material] Composite Film
Lisimin Granules
[Generic Name] Litemin Granules
[Approval Number] National Drug Approval No. Z20025976
[Specification] 5g × 6 sachets/box × 180 boxes/carton
[Packaging Material] Composite Film
Ondansetron Hydrochloride Capsules
[Generic Name] Ondansetron Hydrochloride Capsules
[Approval Number] National Drug Approval No. H10980185
[Specification] 8mg × 3 tablets/box × 200 boxes/carton
[Packaging Material] Aluminum-plastic blister pack
【Medical Insurance】National Medical Insurance Category A
Ondansetron Hydrochloride Capsules
[Generic Name] Ondansetron Hydrochloride Capsules
[Approval Number] National Drug Approval No. H10980185
[Specification] 8mg × 3 tablets/box × 200 boxes/carton
[Packaging Material] Aluminum-plastic blister pack
【Medical Insurance】National Medical Insurance Category A
Ranitidine Hydrochloride Capsules
[Generic Name] Ranitidine Hydrochloride Capsules
[Approval Number] National Drug Approval Number H13022482
【Specification】0.15g × 12 tablets/blister × 3 blisters/box × 300 boxes/carton
[Packaging Material] Aluminum-plastic blister pack
[Medical Insurance] National Medical Insurance Category A
Ranitidine Hydrochloride Capsules
[Generic Name] Ranitidine Hydrochloride Capsules
[Approval Number] National Drug Approval Number H13022482
【Specification】0.15g × 12 tablets/blister × 3 blisters/box × 300 boxes/carton
[Packaging Material] Aluminum-plastic blister pack
[Medical Insurance] National Medical Insurance Category A
Vitamin B6 Injection
[Generic Name] Vitamin B6 Injection
[Approval Number] National Drug Approval Number H13020026
[Specification] 1 ml: 50 mg
[Packaging Material] Glass Ampoule
[Medical Insurance] National Medical Insurance Category A
Vitamin B6 Injection
[Generic Name] Vitamin B6 Injection
[Approval Number] National Drug Approval Number H13020026
[Specification] 1 ml: 50 mg
[Packaging Material] Glass Ampoule
[Medical Insurance] National Medical Insurance Category A
Inosine Injection
[Generic Name] Inosine Injection
[Approval Number] National Drug Approval No. H13022391
[Specification] 2 ml: 50 mg
[Packaging Material] Glass Ampoule
[Medical Insurance] National Medical Insurance Category A
Inosine Injection
[Generic Name] Inosine Injection
[Approval Number] National Drug Approval No. H13022391
[Specification] 2 ml: 50 mg
[Packaging Material] Glass Ampoule
[Medical Insurance] National Medical Insurance Category A
Compound Glycyrrhizic Acid Monosodium Salt Sodium Chloride Injection
[Generic Name] Compound Glycyrrhizic Acid Monosodium Salt Sodium Chloride Injection
[Approval Number] National Drug Approval Number H20050490
[Specification] 100 ml: Contains 80 mg of ammonium glycyrrhizinate, 60 mg of L-cysteine hydrochloride, 0.8 g of glycine, and 0.5 g of sodium chloride.
[Packaging Material] Glass Bottle
Compound Glycyrrhizic Acid Monosodium Salt Sodium Chloride Injection
[Generic Name] Compound Glycyrrhizic Acid Monosodium Salt Sodium Chloride Injection
[Approval Number] National Drug Approval Number H20050490
[Specification] 100 ml: Contains 80 mg of ammonium glycyrrhizinate, 60 mg of L-cysteine hydrochloride, 0.8 g of glycine, and 0.5 g of sodium chloride.
[Packaging Material] Glass Bottle
Ondansetron Hydrochloride Sodium Chloride Injection
[Generic Name] Ondansetron Hydrochloride Sodium Chloride Injection
[Approval Number] National Drug Approval Number H20040028
【Specification】100 ml: Ondansetron 8 mg and Sodium Chloride 0.9 g
[Packaging Material] Non-PVC soft bag/glass bottle
Ondansetron Hydrochloride Sodium Chloride Injection
[Generic Name] Ondansetron Hydrochloride Sodium Chloride Injection
[Approval Number] National Drug Approval Number H20040028
【Specification】100 ml: Ondansetron 8 mg and Sodium Chloride 0.9 g
[Packaging Material] Non-PVC soft bag/glass bottle
Sodium Bicarbonate Injection
[Generic Name] Sodium Bicarbonate Injection
[Approval Number] National Drug Approval Number H13023197
[Specification] 250ml: 12.5g
[Packaging Material] Non-PVC soft bag/PP bottle
【Medical Insurance】National Medical Insurance Category A
Sodium Bicarbonate Injection
[Generic Name] Sodium Bicarbonate Injection
[Approval Number] National Drug Approval Number H13023197
[Specification] 250ml: 12.5g
[Packaging Material] Non-PVC soft bag/PP bottle
【Medical Insurance】National Medical Insurance Category A
SERVICE HOTLINE
Mobile site
E code
